Sarcoma News and Research

RSS
40% of US cancer cases linked to lifestyle choices

40% of US cancer cases linked to lifestyle choices

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Super Surgeons: A Chance at Life returns with new season on Channel 4

Super Surgeons: A Chance at Life returns with new season on Channel 4

Cross-border tumor boards enhance care for rare gynecological cancers across Europe

Cross-border tumor boards enhance care for rare gynecological cancers across Europe

Attenuated virus helps eliminate cancer in mice

Attenuated virus helps eliminate cancer in mice

Innovative FAP-targeted radioligand therapy controls disease progression in sarcoma

Innovative FAP-targeted radioligand therapy controls disease progression in sarcoma

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers

Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers

New Kaposi sarcoma mouse model could be key to drug development

New Kaposi sarcoma mouse model could be key to drug development

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

Drug combination could hold new promise for treating colorectal cancers and other solid tumors

Drug combination could hold new promise for treating colorectal cancers and other solid tumors

Machine learning identifies key cellular communities in soft tissue sarcoma

Machine learning identifies key cellular communities in soft tissue sarcoma

Cedars-Sinai expert explains new treatment options for pediatric patients with sarcomas

Cedars-Sinai expert explains new treatment options for pediatric patients with sarcomas

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

Scientists discover a key mechanism used by human herpesvirus 8 to induce cancer

Scientists discover a key mechanism used by human herpesvirus 8 to induce cancer

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.